There were no significant differences in age at first BC diagnosis, TNM stage, histological grade, multi-focality, lymphovascular invasion (LVI), Ki67 index, chemotherapy, and Her2-targeted therapy (Table 1). Here, ERBB2 is linked to breast cancer.